|
|
|
|
||
Re: bispecifics etc.I asked the Matusow how he felt about about mgd011 vs afm11 since same type of bispecific, said mgd011 Half-Life of 10 days means side affects harder to manage than afm11. MGNX has a huge pipeline, is there a point in deving own pd1 when everyone else is so far along? Also how do you feel about the HIV drug their developing? |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
1558 | Re: bispecifics etc. | JoeFlow | 3 | 7/18/2017 10:08:21 PM |
1559 | Re: bispecifics etc. | JoeFlow | 0 | 7/18/2017 10:12:25 PM |
1560 | Re: bispecifics etc. | JoeFlow | 2 | 7/18/2017 10:21:14 PM |